Comparison of intrauterine PRP versus G-CSF in RIF patients

Phase 3

• Conditions: N97.9; Repeated implantation failure.; Female infertility, unspecified

• Registration Number: IRCT20180528039878N3
• Lead Sponsor: Mehr Medical Institute

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 26 May 2021

Recruitment & Eligibility

• Status: Pending
• Sex: Female
• Target Recruitment: 198

Inclusion Criteria

More than two failed cycles of top and good embryo transfer
Age <41 years

Exclusion Criteria

G-CSF Contraindications,
PRP Contraindications,
Poor ovarian response according to Bologna criteria,
PGS / PGD cycles,
Genetic disorders,
Ovum donor or surrogacy,
Severe endometriosis,
Severe male factor,
No embryo transfer cycles
G-CSF allergy

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Clinical pregnancy. Timepoint: Six weeks after embryo transfer. Method of measurement: Ultrasonography.;Ongoing pregnancy. Timepoint: Twelve weeks after embryo transfer. Method of measurement: Ultrasonography.

Secondary Outcome Measures

Name	Time	Method
Biochemical pregnancy. Timepoint: Two weeks after embryo transfer. Method of measurement: beta-hCG measurement.